Broncho-alveolar lavage (BAL) is an invasive bedside procedure to define type and concentration of pathologic organisms causing ventilator associated pneumonia (VAP). We evaluated if the absence of pathogens on final results represented a lavage aspect of the BAL as a therapeutic procedure to eliminate organisms.
BAL results collected from 2008 to 2009 were stratified as positive (POS) ≥100,000 cfu), indeterminate (INT)≤100,000 cfu pathologic organisms, or negative defined as mixed flora (MF) or sterile (STR). The INT, MF, and STR results were assessed by incidence of a subsequent POS sample.
Nine-hundred forty-nine BALs performed on 490 SICU patients were interpreted as POS in 227 patients (46%). 237 non- POS patients needed a subsequent BAL. Any pathogen on the first BAL (INT group) indicates a high likelihood for subsequent BAL which will be POS. Monthly cumulative sum analysis (CUSUM) of yield was unable to identify any specific period in which BAL performance varied from trend.
MF and STR represent adequate sampling of secretions that are clinically benign. Any pathogen, regardless of concentration, should be considered a biomarker for future pneumonia. CUSUM analysis suggest better training in timing and indication may decrease unnecessary procedures yielding negative results.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Surgery
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.Am J Respir Care Med. 2005; 171: 388-416
- Ventilator-associated pneumonia.Am J Respir Crit Care Med. 2002; 165: 867-903
- Epidemiology and outcomes of ventilator-associated pneumonia in a large US database.Chest. 2002; 122: 2115-2121
- Clinical and economic consequences of ventilator-associated pneumonia: a systematic review.Crit Care Med. 2005; 33: 2184-2193
- Antibiotic resistance in the intensive care unit.Ann Intern Med. 2001; 134: 298-314
- Strategies to prevent antimicrobial resistance in the intensive care unit.Crit Care Med. 2005; 33: 1845-1853
- Nosocomial respiratory infections with gram-negative bacilli. The significance of colonization of the respiratory tract.Ann Intern Med. 1972; 77: 701-706
- Ventilator-associated pneumonia in patients with respiratory failure: A diagnostic approach.Chest. 1990; 97: 1208-1219
- Using bronchoalveolar lavage to distinguish nosocomial pneumonia from systemic inflammatory response syndrome: a prospective analysis.J Trauma. 1995; 39: 1134-1139
- The appropriate diagnostic threshold for ventilator-associated pneumonia using quantitative cultures.J Trauma. 2004; 56: 931-934
- Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia.Chest. 2002; 122: 262-268
- Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia.Chest. 1997; 111: 676-685
- The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia.Chest. 1998; 113: 412-420
- Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription.Am J Respir Crit Care Med. 2000; 162: 505-511
- The role of antimicrobial management programs in optimizing antibiotic prescribing within hospitals.Clin Infect Dis. 2006; 42: S90-S95
- Monitoring surgical performance using risk-adjusted cumulative sum charts.Biostatistics. 2000; 1: 441-452
- Use of risk-adjusted CUSUM and RSPRT charts for monitoring in medical contexts.Stat Methods Med Res. 2003; 12: 147-170
- Continuous inspection schemes.Biometrika. 1954; 41: 100-115
- Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.Intensive Care Med. 2008; 34: 17-60
- Utility of Gram’s stain and efficacy of quantitative cultures for posttraumatic pneumonia: a prospective study.Ann Surg. 1998; 227: 743-755
- Mixed flora: indication for therapy or early warning sign?.Am Surg. 2010; 76: 846-849
- Analysis of charges associated with diagnosis of nosocomial pneumonia: can routine bronchoscopy be justified?.J Trauma. 1994; 37: 721-727
Accepted: July 11, 2011
© 2011 Mosby, Inc. Published by Elsevier Inc. All rights reserved.